UBS Group’s T. Rowe Price US Equity Research ETF TSPA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-6,454
Closed -$276K 11172
2025
Q4
$276K Buy
6,454
+5,340
+479% +$227K ﹤0.01% 6412
2025
Q3
$46.7K Buy
1,114
+1,076
+2,832% +$43.4K ﹤0.01% 7612
2025
Q2
$1.48K Buy
+38
New +$1.37K ﹤0.01% 9617
2023
Q2
Sell
-5,108
Closed -$125K 9668
2023
Q1
$125K Buy
5,108
+4,901
+2,368% +$117K ﹤0.01% 5749
2022
Q4
$4.7K Sell
207
-103
-33% -$2.37K ﹤0.01% 9291
2022
Q3
$7K Buy
+310
New +$7.38K ﹤0.01% 8909

Other funds holding TSPA

UBS Group's TSPA Position: Q1 2026 in Review

UBS Group sold out of T. Rowe Price US Equity Research ETF (TSPA) in Q1 2026, closing a stake of 6,454 shares — an estimated $276K sold.

UBS Group first reported a position in TSPA in Q3 2022 and held it in 6 quarters. The position peaked at $276K in Q4 2025. 119 funds tracked by Wall St. Rank hold TSPA as of Q1 2026.

  • UBS Group reported no remaining T. Rowe Price US Equity Research ETF position as of Q1 2026 after selling out during the quarter.
  • UBS Group sold 6,454 T. Rowe Price US Equity Research ETF shares in Q1 2026, an estimated $276K.
  • UBS Group first reported a position in T. Rowe Price US Equity Research ETF in Q3 2022 and held it in 6 quarters.
  • UBS Group's T. Rowe Price US Equity Research ETF position peaked at $276K in Q4 2025.
  • 119 funds tracked by Wall St. Rank held T. Rowe Price US Equity Research ETF as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.